glucagon-like peptide-1

News

Serena Williams opens up on using weight loss medication

Serena Williams reveals she uses GLP-1 weight loss drug Zepbound: 'I just could never get back to where I needed to be’

Serena Williams has revealed that she's taking a GLP-1 injectable weight loss treatment, in addition to her health regimen.

Fox News on MSN · 17h

Serena Williams opens up about 31-pound weight loss using GLP-1 medication: ‘Something I suffered with’

Serena Williams revealed how she turned her health around with the help of a GLP-1 medication after she struggled to lose weight following the birth of her two daughters.

The State Journal · 3d

Pros and cons of new GLP-1 weight loss/diabetes drugs

Most people have likely heard about the new weight-loss and diabetes management drugs called Ozempic and Mounjaro, which are also called GLP-1 medications, short for glucagon-like peptide-1 agonists,

The American Journal of Managed Care7d

Trends in Glucagon-Like Peptide 1 Receptor Agonist Prescribing Patterns

Glucagon-like peptide 1 receptor agonists, including semaglutide, have increased in use and will continue to increase due to their effectiveness in weight loss.

ConsumerAffairs13d

GLP-1 use surges among perimenopausal women but research hasn't kept up

GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...

3don MSN

GLP-1 drugs linked to reduced symptoms in chronic skin condition hidradenitis suppurativa

A multicenter French study led by Rennes University Hospital reports potential benefits of glucagon-like peptide-1 receptor ...

Managed Healthcare Executive2d

GLP-1 Medications Show Promise in Treating Hidradenitis Suppurativa

GLP-1 receptor agonists show promise in treating hidradenitis suppurativa, offering significant symptom relief and improved ...

The American Journal of Managed Care1d

Building Accountability Into GLP-1 Benefit Design: Lessons From Delaware and Philadelphia

Employers explore glucagon-like peptide-1 (GLP-1) therapies' impact on health benefits, showcasing accountability and ...

National Academies of Sciences%2c Engineering%2c and Medicine11mon

Examining Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonists for ...

Glucagon-like peptide-1 receptor (GLP-1R) agonists, originally developed for type 2 diabetes patients and popularized by their ability to rapidly reduce body weight in patients with obesity, have ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results